Article Versions Notes

Diabaté S, Armand L, Murugadoss S, Dilger M, Fritsch-Decker S, Schlager C, Béal D, Arnal M-E, Biola-Clier M, Ambrose S, et al. Air–Liquid Interface Exposure of Lung Epithelial Cells to Low Doses of Nanoparticles to Assess Pulmonary Adverse Effects. Nanomaterials. 2021; 11(1):65. https://doi.org/10.3390/nano11010065

Diabaté, Silvia, Lucie Armand, Sivakumar Murugadoss, Marco Dilger, Susanne Fritsch-Decker, Christoph Schlager, David Béal, Marie-Edith Arnal, Mathilde Biola-Clier, Selina Ambrose, and et al. 2021. "Air–Liquid Interface Exposure of Lung Epithelial Cells to Low Doses of Nanoparticles to Assess Pulmonary Adverse Effects" Nanomaterials 11, no. 1: 65. https://doi.org/10.3390/nano11010065

Diabaté, S., Armand, L., Murugadoss, S., Dilger, M., Fritsch-Decker, S., Schlager, C., Béal, D., Arnal, M.-E., Biola-Clier, M., Ambrose, S., Mülhopt, S., Paur, H.-R., Lynch, I., Valsami-Jones, E., Carriere, M., & Weiss, C. (2021). Air–Liquid Interface Exposure of Lung Epithelial Cells to Low Doses of Nanoparticles to Assess Pulmonary Adverse Effects. Nanomaterials, 11(1), 65. https://doi.org/10.3390/nano11010065